Clinical trial registries as Scientometric data: A novel solution for linking and deduplicating clinical trials from multiple registries

被引:6
作者
Thiele, Christian [1 ]
Hirschfeld, Gerrit [1 ]
von Brachel, Ruth [2 ]
机构
[1] Univ Appl Sci Bielefeld, Fac Business, OWL Ctr Hlth Welf & Technol, CareTech, Interakt 1, D-33619 Bielefeld, Germany
[2] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, Bochum, Germany
关键词
Clinical trials; Clinical Trial Registries; DRKS; ClinicalTrials; gov; ICTRP; Random Forest; INTERNATIONAL-COMMITTEE; PACKAGE; IMPACT;
D O I
10.1007/s11192-021-04111-w
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Registries of clinical trials are a potential source for scientometric analysis of medical research and serve important functions for the research community and the public at large. Clinical trials that recruit patients in Germany are usually registered in the German Clinical Trials Register (DRKS) or in international registries such as ClinicalTrials.gov. Furthermore, the International Clinical Trials Registry Platform (ICTRP) aggregates trials from multiple primary registries. We queried the DRKS, ClinicalTrials.gov, and the ICTRP for trials with a recruiting location in Germany. Trials that were registered in multiple registries were linked using the primary and secondary identifiers and a Random Forest model based on various similarity metrics. We identified 35,912 trials that were conducted in Germany. The majority of the trials was registered in multiple databases. 32,106 trials were linked using primary IDs, 26 were linked using a Random Forest model, and 10,537 internal duplicates on ICTRP were identified using the Random Forest model after finding pairs with matching primary or secondary IDs. In cross-validation, the Random Forest increased the F1-score from 96.4% to 97.1% compared to a linkage based solely on secondary IDs on a manually labelled data set. 28% of all trials were registered in the German DRKS. 54% of the trials on ClinicalTrials.gov, 43% of the trials on the DRKS and 56% of the trials on the ICTRP were pre-registered. The ratio of pre-registered studies and the ratio of studies that are registered in the DRKS increased over time.
引用
收藏
页码:9733 / 9750
页数:18
相关论文
共 50 条
  • [1] Clinical trial registries as Scientometric data: A novel solution for linking and deduplicating clinical trials from multiple registries
    Christian Thiele
    Gerrit Hirschfeld
    Ruth von Brachel
    Scientometrics, 2021, 126 : 9733 - 9750
  • [2] The many uses of data in public clinical trial registries
    Saberwal, Gayatri
    CURRENT SCIENCE, 2021, 120 (11): : 1686 - 1691
  • [3] Using registries to recruit subjects for clinical trials
    Tan, Meng H.
    Thomas, Matthew
    MacEachern, Mark P.
    CONTEMPORARY CLINICAL TRIALS, 2015, 41 : 31 - 38
  • [4] Rare use of patient-reported outcomes in childhood cancer clinical trials-a systematic review of clinical trial registries
    Riedl, David
    Rothmund, Maria
    Darlington, Anne-Sophie
    Sodergren, Samantha
    Crazzolara, Roman
    de Rojas, Teresa
    EUROPEAN JOURNAL OF CANCER, 2021, 152 : 90 - 99
  • [5] Improving Investigative Site Contact Options on Clinical Trial Registries:: Making It Easier for Patients to Find Clinical Trials
    Polidori, Christa Patterson
    Su, Mandy S.
    Jakee, Kelsey
    Hodge, Keir
    Ancona, Crystal
    Yoder, Joseph
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (05) : 534 - 541
  • [6] Implementing registries and results databases of clinical trials: is there a side effect?
    Dahm, Matthias
    Gonzalez, Paula
    Porteiro, Nicolas
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (03) : 247 - 251
  • [7] Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries
    Aurélie De Bruycker
    Phuoc T. Tran
    Ariel H. Achtman
    Piet Ost
    World Journal of Urology, 2021, 39 : 317 - 326
  • [8] Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries
    Mavundza, Edison Johannes
    Mmotsa, Tshiamo Moshading
    Ndwandwe, Duduzile
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [9] Clinical perspectives from ongoing trials in oligometastatic or oligorecurrent prostate cancer: an analysis of clinical trials registries
    De Bruycker, Aurelie
    Tran, Phuoc T.
    Achtman, Ariel H.
    Ost, Piet
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 317 - 326
  • [10] Clinical Trial Registries: An Industry Perspective
    McLean, Lia
    DRUG INFORMATION JOURNAL, 2010, 44 (03): : 279 - 287